Equities Analysts Offer Predictions for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Zacks Research lowered their FY2024 earnings per share estimates for Acadia Healthcare in a research report issued on Wednesday, November 13th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $3.37 for the year, down from their prior estimate of $3.46. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.71 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.94 EPS, Q1 2026 earnings at $0.88 EPS, Q2 2026 earnings at $0.99 EPS, Q3 2026 earnings at $1.07 EPS and FY2026 earnings at $3.99 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same quarter last year, the firm posted $0.91 EPS. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year.

ACHC has been the subject of a number of other reports. Royal Bank of Canada decreased their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Barclays cut their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $83.33.

Acadia Healthcare Trading Down 1.8 %

NASDAQ:ACHC opened at $37.13 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The company has a market cap of $3.45 billion, a PE ratio of 12.17, a PEG ratio of 1.68 and a beta of 1.33. The firm has a 50-day moving average of $57.27 and a 200-day moving average of $65.34.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. purchased a new stake in Acadia Healthcare during the second quarter valued at about $800,000. TCW Group Inc. raised its position in shares of Acadia Healthcare by 63.8% in the second quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock valued at $4,247,000 after purchasing an additional 24,487 shares during the period. SG Americas Securities LLC lifted its stake in shares of Acadia Healthcare by 435.6% during the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock valued at $1,231,000 after buying an additional 14,824 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Acadia Healthcare by 19.4% in the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after buying an additional 104,359 shares during the period. Finally, Texas Permanent School Fund Corp grew its stake in Acadia Healthcare by 11.3% in the 2nd quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock valued at $6,067,000 after buying an additional 9,115 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.